Sveriges Riksbank
| Bid date, 2021-02-26 | |
| Bid Submission Date | 2021-02-26 |
| Bid times | 10.30-11.00 (CET/CEST) on the Bid date |
| Offered Amount | 50 billion SEK |
| Maximum Permitted Bid Volume | 12.5 billion SEK from an individual bidder |
| Settlement Date | 2021-03-02 |
| Minimum Permitted Bid Volume | 10 million SEK per bid |
| Final Repayment Date | 2025-03-03 |
| Maximum Allocation | 25 per cent of Offered Amount |
| Allocation Time | Not later than 11.30 (CET/CEST) on the Bid date |
| Repayment Date | 2022-03-02 |
| Option Repayment Date 1 | 2023-03-02 |
| Option Repayment Date 2 | 2024-03-04 |
| Interest rate | The Riksbank´s applicable repo rate |
| Additional interest rate | 0.10 per cent |
| Confirmation of bids to e-mail | eol@riksbank.se |
Stockholm, 2021-02-24
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ecorobotix SA8.11.2025 12:15:00 CET | Press release
Ecorobotix Showcases World-First AI Capability for Safe, Targeted Use of Non-Selective Contact Herbicides at Agritechnica
IOT Squared8.11.2025 11:00:00 CET | Press release
Saudi “Emerge” Emergency and Crisis Resilience Platform Named Among the World’s Best Smart City Solutions in the 2025 Smart City Awards
Novo Nordisk A/S8.11.2025 09:18:56 CET | Press release
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Columbus A/S7.11.2025 23:46:30 CET | Press release
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
